As of Mar 23
| +0.05 / +1.06%|
The 1 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. The median estimate represents a +215.79% increase from the last price of 4.75.
The current consensus among 2 polled investment analysts is to Buy stock in Juniper Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.